Hub : Traits

Tail length

Tags: Physiology

Project: dissection

17 loci · 46 genes with independent associations · 504 total associated genes

Significant Loci

#	Chr	Start pos	End pos	# assoc genes	# joint models	Best TWAS P	Best GWAS P	Cond GWAS P	Joint genes
1	chr1	11374647	13009428	12	1	1.78e-09	3.39e-08	1.00e+00	LOC102546604
2	chr1	154359040	158950354	47	1	1.35e-08	2.28e-08	1.41e-01	Nup98
3	chr2	34332644	36052915	15	1	7.89e-08	1.23e-07	1.00e+00	Nln
4	chr3	121057309	123489307	15	2	2.76e-09	6.30e-10	3.72e-14	Plcb1
5	chr4	128043315	129441244	2	1	7.20e-08	4.73e-08	1.00e+00	LOC102549269
6	chr7	27131289	30904027	45	6	1.20e-14	2.08e-13	NaN	LOC102553539 Metap2 Nudt4 Plxnc1 Socs2 Tmcc3
7	chr9	50034515	51433051	1	1	2.02e-07	8.16e-08	1.00e+00	Tmeff2
8	chr9	54140250	57601104	43	1	2.53e-12	1.42e-12	1.00e+00	Stk17b
9	chr9	58867320	60264237	2	1	1.39e-07	2.52e-07	1.00e+00	Kctd18
10	chr9	67025649	69247638	21	8	1.39e-08	1.29e-08	1.00e+00	Kansl1l Lancl1 Map2 Rpe
11	chr9	75969545	77365260	1	1	9.84e-85	2.39e-02	1.00e+00	Zfand2b
12	chr10	79659766	83433454	164	6	5.55e-16	9.30e-15	1.00e+00	LOC120095180 Mrpl45 Scrn2 Srcin1 Zfp652
13	chr10	105364159	106761673	1	1	1.79e-07	2.45e-07	1.34e-01	Dus1l
14	chr12	22091	4504120	64	6	2.85e-09	2.85e-09	1.00e+00	Brca2 Insr LOC120095871 Pet100 Snapc2
15	chr12	5928407	7325669	1	1	8.12e-08	6.13e-08	1.00e+00	Slc7a1
16	chr13	97821599	99484838	2	1	2.13e-07	2.01e-07	1.00e+00	Gpatch2
17	chr20	883910	6661192	68	7	2.78e-09	3.01e-08	NaN	Abcf1 Dhx16 LOC108353253 LOC120093125 Lst1 RT1-CE4 RT1-N3

Pleiotropic Associations

Trait	Chi2 ratio	# genes+	# genes++	% genes++	Corr	Corr P	Genes
BMI with tail	13.12	48	39	84.8	-0.98	1.13e-287	Abi3 Atp5mc1 B4galnt2 Calcoco2 Cbx1 Cdk5rap3 Copz2 Gip Gngt2 Gpr179 Hoxb2 Hoxb3 Hoxb4 Hoxb7 Hoxb9 Kctd18 Kpnb1 LOC102547047 LOC102547278 LOC102547955 LOC102550580 LOC108352124 LOC120095179 LOC120095180 Lrrc46 Mrpl10 Mrpl45 Nfe2l1 Npepps Osbpl7 Phb1 Phf1 Phospho1 Pnpo Prr15l Scrn2 Skap1 Slc39a10 Snf8 Snx11 Sp2 Spop Srcin1 Tbkbp1 Tmeff2 Ube2z Zfand2b Zfp652
BMI without tail	11.86	8	1	2.2	0.99	7.41e-12	Ccdc38 Dus1l LOC102553539 Lta4h Mir331 Ntn4 Vezt Zfand2b
Body weight	12.46	59	47	102.2	0.98	1.22e-170	Abcf1 Amdhd1 Arhgef18 Brca2 Ccdc38 Cchcr1 Cep83 Cers4 Cradd Ddr1 Dhx16 Elavl1 Elk3 Fgd6 Gnl1 Insr Kl LOC102549089 LOC102553539 LOC108349027 LOC108351432 LOC120093125 LOC120093559 LOC120093563 LOC120095871 LOC120098967 Lta4h Mcoln1 Metap2 Mir331 Mrpl42 N4bp2l1 N4bp2l2 Ndufa12 Nr2c1 Ntn4 Nudt4 Pet100 Pex11g Plxnc1 Prr3 RT1-CE10 RT1-CE14 RT1-CE15 RT1-CE16 RT1-M6-2 RT1-N2 RT1-N3 RT1-S3 RT1-T24-2 RT1-T24-4 Snapc2 Socs2 Stard13 Stxbp2 Tmcc3 Ube2n Vezt Xab2
Epididymis fat weight	22.22	7	3	6.5	0.42	3.01e-01	Ilrun LOC108353253 Map2 Nudt3 Phf1 Taf11 Zfand2b
Glucose	11.95	1	0	0	0	1.00e+00	Phf1
Heart weight	71.7	1	1	2.2	0	1.00e+00	Zfand2b
Left kidney weight	11.73	18	16	34.8	0.87	5.92e-29	Arhgef18 Brca2 Cers4 Elavl1 Insr Kl LOC102549089 LOC120095871 Mcoln1 N4bp2l1 N4bp2l2 Pet100 Pex11g Snapc2 Stard13 Stxbp2 Xab2 Zfand2b
Right kidney weight	9.64	18	15	32.6	0.82	1.73e-23	Arhgef18 Brca2 Cers4 Elavl1 Insr Kl LOC102549089 LOC120095871 Mcoln1 N4bp2l1 N4bp2l2 Pet100 Pex11g Snapc2 Stard13 Stxbp2 Xab2 Zfand2b
Length with tail	10.42	168	119	258.7	0.97	0.00e+00	Abcf1 Abi3 Acadl Amdhd1 Anapc15 Ankrd44 Arhgef18 Atg16l2 Atp5mc1 B4galnt2 Brca2 Calcoco2 Cbx1 Ccdc38 Cchcr1 Cdk5rap3 Cenpk Cep83 Cers4 Cited2 Copz2 Coq10b Cradd Ddr1 Ddx3y Dhx16 Dnah7 Elavl1 Elk3 Erbin Fam168a Fchsd2 Fgd6 Folr1 Folr2 Gip Gngt2 Gnl1 Gpatch2 Gpr179 Hbb Hbb-b1 Hbb-b2 Hbb-bs Hecw2 Hoxb2 Hoxb3 Hoxb4 Hoxb7 Hoxb9 Hspd1 Il18bp Ilrun Inppl1 Insr Kansl1l Kctd18 Kl Kpnb1 Lancl1 LOC100134871 LOC102546541 LOC102546604 LOC102547047 LOC102547278 LOC102547955 LOC102549089 LOC102550580 LOC102553539 LOC103691897 LOC108349027 LOC108351432 LOC108352124 LOC120093125 LOC120093559 LOC120093563 LOC120094685 LOC120095179 LOC120095180 LOC120095871 LOC120097890 LOC120098967 LOC120100694 LOC686030 Lrrc46 Lta4h Map2 Mars2 Mcoln1 Metap2 Mir331 Mob4 Mrpl10 Mrpl42 Mrpl45 N4bp2l1 N4bp2l2 Ndufa12 Nfe2l1 Nln Npepps Nr2c1 Ntn4 Nudt4 Numa1 Nup98 Olr59 Osbpl7 Pet100 Pex11g Pgap1 Pgap2 Phb1 Phospho1 Pip4k2b Plcb1 Plcb4 Plcl1 Plxnc1 Pnpo Ppwd1 Prr15l Prr3 Rftn2 Rnf121 Rpe RT1-CE10 RT1-CE13 RT1-CE14 RT1-CE15 RT1-CE16 RT1-M6-2 RT1-N2 RT1-N3 RT1-S3 RT1-T24-2 RT1-T24-4 Scrn2 Sf3b1 Sgtb Skap1 Slc39a10 Slc7a1 Snapc2 Snf8 Snx11 Socs2 Sp2 Spop Srcin1 Stard10 Stard13 Stk17b Stxbp2 Tbkbp1 Tmcc3 Tmeff2 Tmx4 Trappc13 Trim21 Trim68 Ube2n Ube2z Vezt Xab2 Xndc1 Zfand2b Zfp652
Length without tail	10.98	34	13	28.3	0.86	4.53e-38	Amdhd1 Arhgef18 Brca2 Cers4 Elavl1 Fgd6 Insr Kl LOC102549089 LOC102553539 LOC120093563 LOC120095871 Lta4h Mcoln1 Mir331 Mrpl42 N4bp2l1 N4bp2l2 Ndufa12 Nln Nr2c1 Ntn4 Pet100 Pex11g Plxnc1 Ppwd1 Snapc2 Stard13 Stxbp2 Tmcc3 Trappc13 Vezt Xab2 Zfand2b
Liver weight, right	15.31	3	2	4.3	0	1.00e+00	Ilrun Nudt3 Zfand2b
Parametrial fat weight	9.99	1	0	0	0	1.00e+00	Zfand2b
Retroperitoneal fat weight	7.53	1	0	0	0	1.00e+00	Zfand2b
Intraocular pressure	51.69	1	1	2.2	0	1.00e+00	Zfand2b
Extensor digitorum longus weight	6.11	22	6	13	0.82	8.38e-26	Arhgef18 Brca2 Cenpk Cers4 Elavl1 Insr Kl LOC102549089 LOC120095871 Mcoln1 N4bp2l1 N4bp2l2 Nln Pet100 Pex11g Ppwd1 Sgtb Snapc2 Stard13 Stxbp2 Trappc13 Xab2
Soleus weight	8.6	3	1	2.2	0	1.00e+00	Ilrun Nudt3 Taf11
Tibialis anterior weight	8.22	17	16	34.8	1	5.61e-107	Arhgef18 Brca2 Cers4 Elavl1 Insr Kl LOC102549089 LOC120095871 Mcoln1 N4bp2l1 N4bp2l2 Pet100 Pex11g Snapc2 Stard13 Stxbp2 Xab2
Tibia length	8.46	49	15	32.6	0.99	1.24e-152	Amdhd1 Ankrd44 Brca2 Ccdc38 Cchcr1 Cep83 Coq10b Dnah7 Elavl1 Elk3 Erbin Fgd6 Hecw2 Hspd1 Insr LOC102549089 LOC102553539 LOC120093563 LOC120094685 LOC120100694 Lta4h Mars2 Mcoln1 Mir331 Mob4 Mrpl42 N4bp2l1 N4bp2l2 Ndufa12 Nln Nr2c1 Ntn4 Pet100 Pgap1 Plcl1 Plxnc1 Ppwd1 Rftn2 Sf3b1 Sgtb Slc39a10 Snapc2 Socs2 Stard13 Stk17b Tmcc3 Trappc13 Ube2n Vezt
Number of licking bursts	32.5	1	1	2.2	0	1.00e+00	Zfand2b
Food consumed during 24 hour testing period	15.78	1	0	0	0	1.00e+00	Zfand2b
Mean time between licks in bursts	12.43	1	0	0	0	1.00e+00	LOC102546541
Mean num. licks in bursts	18.13	1	0	0	0	1.00e+00	Zfand2b
Water consumed over 24 hours	34.33	1	1	2.2	0	1.00e+00	Zfand2b
Patch foraging indifference point 0 sec	11.8	1	0	0	0	1.00e+00	Zfand2b
Patch foraging indifference point AUC	24.2	1	1	2.2	0	1.00e+00	Zfand2b
Indifference point function ln k	54.42	1	1	2.2	0	1.00e+00	Zfand2b
Indifference point function log k	54.42	1	1	2.2	0	1.00e+00	Zfand2b
Patch foraging total patch changes 0 sec	23.48	1	1	2.2	0	1.00e+00	Zfand2b
Patch foraging total patch changes 18 sec	48.28	1	1	2.2	0	1.00e+00	Zfand2b
Patch foraging total patch changes 24 sec	77.61	1	1	2.2	0	1.00e+00	Zfand2b
Patch foraging total patch changes 6 sec	24.67	1	1	2.2	0	1.00e+00	Zfand2b
Patch foraging time to switch 0 sec	33.47	1	1	2.2	0	1.00e+00	Zfand2b
Patch foraging water rate 0 sec	39.47	1	1	2.2	0	1.00e+00	Zfand2b
Patch foraging water rate 12 sec	69.49	1	1	2.2	0	1.00e+00	Zfand2b
Patch foraging water rate 24 sec	12.61	1	0	0	0	1.00e+00	Zfand2b
Patch foraging water rate 6 sec	14.61	8	1	2.2	0.48	3.57e-02	Cenpk Erbin LOC120100694 Nln Ppwd1 Sgtb Trappc13 Zfand2b
Locomotor activity	12.38	1	0	0	0	1.00e+00	Zfand2b
Locomotor testing distance	47.2	1	1	2.2	0	1.00e+00	Zfand2b
Locomotor testing rearing	99.51	1	1	2.2	0	1.00e+00	Zfand2b
Light reinforcement 1	19.25	1	1	2.2	0	1.00e+00	Zfand2b
Reaction time number correct	114.79	1	1	2.2	0	1.00e+00	Zfand2b
Reaction time mean minus median	179.03	1	1	2.2	0	1.00e+00	Zfand2b
Reaction time mean minus median AUC	232.47	1	1	2.2	0	1.00e+00	Zfand2b
Reaction time num false alarms AUC	27.43	1	1	2.2	0	1.00e+00	Zfand2b
Reaction time trials correct on left	114.79	1	1	2.2	0	1.00e+00	Zfand2b
Reaction time trials on left	106.69	1	1	2.2	0	1.00e+00	Zfand2b
Reaction time mean	36.11	1	1	2.2	0	1.00e+00	Zfand2b
Reaction time mean AUC	33.75	1	1	2.2	0	1.00e+00	Zfand2b
Median of all reaction times	17.65	1	0	0	0	1.00e+00	Zfand2b
Reaction time omissions	46.56	1	1	2.2	0	1.00e+00	Zfand2b
Reaction time premature initiations	19.14	4	1	2.2	-0.35	6.46e-01	LOC120100694 Ppwd1 Trappc13 Zfand2b
Std. dev. reaction times	72.92	1	1	2.2	0	1.00e+00	Zfand2b
Reaction time trials completed	106.69	1	1	2.2	0	1.00e+00	Zfand2b
Reaction time trials AUC	108.76	1	1	2.2	0	1.00e+00	Zfand2b
Cocaine response before conditioning	14.22	3	0	0	1	2.67e-03	Lst1 RT1-CE4 RT1-CE7
Condit. Reinf. active responses	12.81	8	0	0	1	1.47e-18	Atg16l2 Fam168a Folr1 Folr2 LOC102546541 Numa1 Rnf121 Stard10
Condit. Reinf. lever presses	14.02	9	0	0	1	4.61e-19	Atg16l2 Fam168a Folr1 Folr2 LOC102546541 Numa1 Pgap2 Rnf121 Stard10
Condit. Reinf. lever reinforcers received	12.93	8	0	0	1	4.46e-18	Fam168a Folr1 Folr2 LOC102546541 Numa1 Pgap2 Rnf121 Stard10
Pavlov. Cond. lever latency	13.78	8	0	0	-1	1.37e-14	Atg16l2 Fam168a Folr1 Folr2 LOC102546541 Numa1 Pgap2 Rnf121
Pavlov. Cond. change in total contacts	13.03	1	0	0	0	1.00e+00	Folr2
Pavlov. Cond. lever contacts	14.03	10	0	0	1	1.09e-18	Atg16l2 Fam168a Folr1 Folr2 LOC102546541 Numa1 Pgap2 Rnf121 Stard10 Trim68
Pavlov. Cond. response bias	13.71	7	0	0	1	3.72e-11	Atg16l2 Fam168a Folr1 Folr2 LOC102546541 Pgap2 Rnf121
Conditioned reinforcement - actives	152.54	1	1	2.2	0	1.00e+00	Zfand2b
Conditioned reinforcement - inactives	135.63	1	1	2.2	0	1.00e+00	Zfand2b
Conditioned locomotion	13.93	1	0	0	0	1.00e+00	Zfand2b
Intermittent access intake day 1-15 change	156.77	1	1	2.2	0	1.00e+00	Zfand2b
Intermittent access intake escalation	117.41	1	1	2.2	0	1.00e+00	Zfand2b
Intermitt. access day 1 inactive lever presses	169.63	1	1	2.2	0	1.00e+00	Zfand2b
Intermitt. access day 15 inactive lever presses	294.26	1	1	2.2	0	1.00e+00	Zfand2b
Intermittent access day 1 total infusions	71.42	1	1	2.2	0	1.00e+00	Zfand2b
Intermittent access day 15 total infusions	35.39	1	1	2.2	0	1.00e+00	Zfand2b
Intermittent access terminal intake (last 3 days)	25.82	1	1	2.2	0	1.00e+00	Zfand2b
Intermittent access day 1 locomotion	26.47	1	1	2.2	0	1.00e+00	Zfand2b
Intermittent access day 15 total locomotion	93.08	1	1	2.2	0	1.00e+00	Zfand2b
Intermittent access standard deviation	442.51	1	1	2.2	0	1.00e+00	Zfand2b
Cocaine induced anxiety	125.35	1	1	2.2	0	1.00e+00	Zfand2b
Baseline Anxiety	393.92	1	1	2.2	0	1.00e+00	Zfand2b
Incentive Sensitization - Responses	309.83	1	1	2.2	0	1.00e+00	Zfand2b
Incentive Sensitization - Breakpoint	300.45	1	1	2.2	0	1.00e+00	Zfand2b
Progressive ratio test 1 active lever presses	26.41	1	1	2.2	0	1.00e+00	Zfand2b
Progressive ratio test 1 breakpoint	19.19	1	0	0	0	1.00e+00	Zfand2b
Progressive ratio test 2 active lever presses	109.22	1	1	2.2	0	1.00e+00	Zfand2b
Progressive ratio test 2 breakpoint	106.65	1	1	2.2	0	1.00e+00	Zfand2b
Progressive ratio test 2 inactive lever presses	63.47	1	1	2.2	0	1.00e+00	Zfand2b
Short access day 1 total inactive lever presses	21.93	1	0	0	0	1.00e+00	Zfand2b
Short access day 10 total inactive lever presses	43.04	1	1	2.2	0	1.00e+00	Zfand2b
Short access day 1 locomotion	72.97	2	1	2.2	0	1.00e+00	Phf1 Zfand2b
Short access day 10 total locomotion	432.47	1	1	2.2	0	1.00e+00	Zfand2b
Short access total locomotion	209.96	1	1	2.2	0	1.00e+00	Zfand2b
Compulsive drug intake	68.39	1	1	2.2	0	1.00e+00	Zfand2b
One hour access (0.3 mA shock)	22.58	1	0	0	0	1.00e+00	Zfand2b
One hour access (shock baseline)	14.47	1	0	0	0	1.00e+00	LOC120093563
Number of responses in last shaping day	67.75	1	1	2.2	0	1.00e+00	Zfand2b
Locomotion distance, session 7	14.25	1	0	0	0	1.00e+00	RT1-CE5
Condit. Reinf. active minus inactive responses	14.99	1	0	0	0	1.00e+00	Phf1
Bone surface	10.35	1	0	0	0	1.00e+00	Snapc2
Bone: connectivity density	11.55	3	0	0	1	5.51e-06	Cers4 LOC120095871 Snapc2
Bone: endosteal estimation	8.54	20	0	0	1	3.78e-66	Abcf1 Cchcr1 Dhx16 LOC108349027 LOC120093125 LOC120098967 Neu1 Prr3 RT1-CE10 RT1-CE11 RT1-CE12 RT1-CE13 RT1-CE14 RT1-CE15 RT1-CE16 RT1-CE4 RT1-M6-2 RT1-N2 RT1-N3 RT1-S3
Bone: marrow area	8.52	20	0	0	1	2.08e-66	Abcf1 Cchcr1 Dhx16 LOC108349027 LOC120093125 LOC120098967 Neu1 Prr3 RT1-CE10 RT1-CE11 RT1-CE12 RT1-CE13 RT1-CE14 RT1-CE15 RT1-CE16 RT1-CE4 RT1-M6-2 RT1-N2 RT1-N3 RT1-S3
Delta time in open arm before/after self-admin	26.67	1	0	0	0	1.00e+00	Zfand2b
Active lever presses in extinction session 6	26.41	1	0	0	0	1.00e+00	Zfand2b
Time in closed arm before self-admin	44.32	1	1	2.2	0	1.00e+00	Zfand2b
Time in open arm before self-admin	24.67	1	0	0	0	1.00e+00	Zfand2b
Time to tail flick, vehicle, after self-admin	75.62	1	1	2.2	0	1.00e+00	Zfand2b
Delta time to tail flick, vehicle, before/after SA	74.6	1	1	2.2	0	1.00e+00	Zfand2b
Ambulatory time before self-admin	25.36	1	0	0	0	1.00e+00	Zfand2b
Area under the delay curve	31.15	1	1	2.2	0	1.00e+00	Zfand2b
Delay disc. indifference point, 16s delay	69.03	1	1	2.2	0	1.00e+00	Zfand2b
Delay disc. indifference point, 24s delay	27.43	1	0	0	0	1.00e+00	Zfand2b
Delay disc. indifference point, 4s delay	16.28	1	0	0	0	1.00e+00	Gpr179
Delay disc. indifference point, 8s delay	74.24	1	1	2.2	0	1.00e+00	Zfand2b
Delay discount exponential model param	16.14	1	0	0	0	1.00e+00	Zfand2b
Delay discount hyperbolic model param	15.89	1	0	0	0	1.00e+00	Zfand2b
Fecal boli incidents, locomotor time 1	176.47	1	1	2.2	0	1.00e+00	Zfand2b
Time >=10cm from walls, locomotor time 1	79.04	1	1	2.2	0	1.00e+00	Zfand2b
Vertical activity count, locomotor time 1	97.7	1	1	2.2	0	1.00e+00	Zfand2b
Bouts of movement, locomotor time 2	23.9	1	0	0	0	1.00e+00	Zfand2b
Total resting periods, locomotor time 2	36.28	1	1	2.2	0	1.00e+00	Zfand2b
Rest time, locomotor task time 2	44.91	1	1	2.2	0	1.00e+00	Zfand2b
Distance moved, locomotor task time 2	83.87	1	1	2.2	0	1.00e+00	Zfand2b
Locomotion in novel chamber post-restriction	14.04	1	0	0	0	1.00e+00	Zfand2b
Food seeking constrained by brief footshock	14.98	1	0	0	0	1.00e+00	Zfand2b
Run reversals in cocaine runway, females	36.45	1	1	2.2	0	1.00e+00	Zfand2b
Latency to leave start box in cocaine runway	34.23	1	1	2.2	0	1.00e+00	Zfand2b
Latency to leave start box in cocaine runway, F	31.9	1	1	2.2	0	1.00e+00	Zfand2b
Cu content in liver	14.54	3	0	0	0.99	5.70e-03	LOC120095179 Snf8 Zfp652

Associations by panel

Tissue	RNA modality	# hits	% hits/tests	Avg chisq
Adipose	alternative polyA	14	0.4	2.77
Adipose	alternative TSS	34	1	3.38
Adipose	gene expression	40	0.4	2.98
Adipose	isoform ratio	22	0.5	2.98
Adipose	intron excision ratio	26	0.8	3.47
Adipose	mRNA stability	17	0.4	2.87
BLA	alternative polyA	10	0.5	3.07
BLA	alternative TSS	9	0.5	3.03
BLA	gene expression	37	0.5	3.01
BLA	isoform ratio	17	0.6	3.19
BLA	intron excision ratio	9	0.3	3.21
BLA	mRNA stability	16	0.7	3.03
Brain	alternative polyA	12	0.3	2.89
Brain	alternative TSS	18	0.4	3.11
Brain	gene expression	40	0.4	2.86
Brain	isoform ratio	22	0.4	3.02
Brain	intron excision ratio	18	0.3	3.25
Brain	mRNA stability	17	0.3	2.81
Eye	alternative polyA	0	0	3.09
Eye	alternative TSS	0	0	3.26
Eye	gene expression	5	0.4	2.9
Eye	isoform ratio	4	0.7	3.37
Eye	intron excision ratio	11	1.2	3.91
Eye	mRNA stability	1	0.3	3.25
IL	alternative polyA	2	0.2	3.14
IL	alternative TSS	0	0	2.7
IL	gene expression	16	0.4	2.91
IL	isoform ratio	4	0.3	3.01
IL	intron excision ratio	4	0.4	3.19
IL	mRNA stability	5	0.4	2.93
LHb	alternative polyA	3	0.3	3.45
LHb	alternative TSS	2	0.3	2.99
LHb	gene expression	16	0.4	2.84
LHb	isoform ratio	2	0.2	3.11
LHb	intron excision ratio	5	0.4	3.52
LHb	mRNA stability	7	0.6	2.8
Liver	alternative polyA	17	0.6	2.93
Liver	alternative TSS	27	1	3.2
Liver	gene expression	42	0.5	2.96
Liver	isoform ratio	20	0.5	3.03
Liver	intron excision ratio	18	0.4	3.1
Liver	mRNA stability	20	0.7	3.03
NAcc	alternative polyA	8	0.3	3.04
NAcc	alternative TSS	12	0.4	3.02
NAcc	gene expression	40	0.5	2.96
NAcc	isoform ratio	22	0.5	3.19
NAcc	intron excision ratio	12	0.2	3.07
NAcc	mRNA stability	14	0.4	2.94
OFC	alternative polyA	3	0.3	2.99
OFC	alternative TSS	3	0.4	3.29
OFC	gene expression	15	0.4	2.89
OFC	isoform ratio	5	0.4	3.08
OFC	intron excision ratio	4	0.3	3.63
OFC	mRNA stability	3	0.2	2.8
PL	alternative polyA	17	0.5	3.02
PL	alternative TSS	16	0.5	3.14
PL	gene expression	35	0.4	2.9
PL	isoform ratio	18	0.4	3.14
PL	intron excision ratio	21	0.4	3.32
PL	mRNA stability	19	0.5	2.91
pVTA	alternative polyA	3	0.2	2.86
pVTA	alternative TSS	10	0.7	3.31
pVTA	gene expression	21	0.4	2.91
pVTA	isoform ratio	8	0.4	3.15
pVTA	intron excision ratio	6	0.2	3.36
pVTA	mRNA stability	11	0.8	3
RMTg	alternative polyA	2	0.3	3.04
RMTg	alternative TSS	2	0.4	2.87
RMTg	gene expression	7	0.4	2.99
RMTg	isoform ratio	2	0.3	2.8
RMTg	intron excision ratio	3	0.4	3.54
RMTg	mRNA stability	2	0.3	2.77